AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
Why Gold Is Going Up
TLDR
Success of Novo Nordisk's GLP1 Drugs: From Type 2 Diabetes to New Frontiers
Exploring Novo Nordisk's success with GLP1 drugs in treating type 2 diabetes and potential new applications in areas like weight loss and Parkinson's disease. Discussion on market impact, implications for accessibility and affordability, and the optimistic outlook for broad-based supply and cost reduction.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode